Switch to: References

Add citations

You must login to add citations.
  1. The case for regulating intragenic GMOs.A. Wendy Russell & Robert Sparrow - 2008 - Journal of Agricultural and Environmental Ethics 21 (2):153-181.
    This paper discusses the ethical and regulatory issues raised by ‘‘intragenics’’ – organisms that have been genetically modified using gene technologies, but that do not contain DNA from another species. Considering the rapid development of knowledge about gene regulation and genomics, we anticipate rapid advances in intragenic methods. Of regulatory systems developed to govern genetically modified organisms (GMOs) in North America, Europe, Australia, and New Zealand, the Australian system stands out in explicitly excluding intragenics from regulation. European systems are also (...)
    Download  
     
    Export citation  
     
    Bookmark   2 citations  
  • Intellectual property and biotechnology: theoretical arguments and empirical evidence.Clarissa Allen - unknown
    DNA patents have been being granted since the 1970s. Patents are meant to act as incentives, encouraging innovation and dissemination in biotechnology by granting inventors exclusive economic control of their inventions for a set period of time. Governments in North America and Europe have therefore been using patents as a public policy tool to encourage the invention of health-related biotechnologies since the 1980s and 1990s, respectively. However despite this laudable policy goal, there have also in recent decades been a number (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Locating Gene patents within the patent system.Arti K. Rai - 2002 - American Journal of Bioethics 2 (3):18 – 19.
    Download  
     
    Export citation  
     
    Bookmark